BusinessNew published evidence reinforces the importance of device choice in asthma controlBy Nasdaq OMXJan 31, 2018, 1:45 PM UTC
BusinessParion Sciences Announces Presentation of Clinical Data with Novel Pulmonary Delivery Device at the 2016 North American Cystic Fibrosis ConferenceBy Nasdaq OMXOct 25, 2016, 12:14 PM UTC
BusinessCardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines AgencyBy Nasdaq OMXJan 6, 2016, 1:00 PM UTC
